Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B

The Case Report was published on 21 Jun 2019.

The author's statement of conflict of interest was confused with the original and published incorrectly due to the negligence of the Editorial Office. Here is the correction:

Conflict of Interest:

Hie-Won Hann: Clinical Research Grant from Gilead, Assembly Biosciences, Arbutus and serves at the National Advisory Board of Gilead Sciences.

Ralph Zinner: Bristol Myers Squibb, Merck

Peter Block, Brianna Shinn, Christopher Roth, Jeffrey Baliff: No conflict of Interest.

We, Editorial Office of Hepatoma Research apologize for any inconvenience we may cause.